[Treatment of early menopause. A report of 2 cases].
Veralipride was given to two patients with early menopause ascertained by hormonal investigations. In both women (aged 33 and 30 years), an estradiol-progestogen combination given for hot flushes, disorders of character, and depression, had been unsuccessful. Symptoms resolved under therapy with veralipride alone or associated with the previous treatment. In one patient, symptoms recurred after veralipride was discontinued and resolved again once the drug was resumed.
D000328:Adult; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008594:Menopause, Premature / Q000187:drug effects*; D009653:Norprogesterones / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use
D009653:Norprogesterones; D011374:Progesterone; D004958:Estradiol; C011214:demegestone; D013469:Sulpiride; C027429:veralipride
Traitement de la ménopause précoce. A propos de deux observations.